| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 1.58e-11 | 5 | 140 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 9.41e-11 | 6 | 140 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 6.47e-08 | 16 | 140 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | calcium ion binding | SELP AMY1A AMY1B AMY1C AMY2A AMY2B PCDHGB5 DNER TENM2 MICU1 CD93 USP6 THBS4 DST USP32 LTBP1 CALN1 PROS1 | 5.16e-06 | 749 | 140 | 18 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.23e-05 | 73 | 140 | 6 | GO:0050840 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.51e-05 | 188 | 140 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 8.73e-05 | 103 | 140 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 5.38e-04 | 144 | 140 | 6 | GO:0016798 | |
| Domain | Glyco_hydro_13_cat_dom | 4.10e-10 | 7 | 137 | 5 | IPR006047 | |
| Domain | Alpha-amylase | 4.10e-10 | 7 | 137 | 5 | PF00128 | |
| Domain | Aamy | 4.10e-10 | 7 | 137 | 5 | SM00642 | |
| Domain | Alpha_amylase | 2.77e-09 | 4 | 137 | 4 | IPR006046 | |
| Domain | Aamy_C | 2.77e-09 | 4 | 137 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 1.38e-08 | 5 | 137 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 1.38e-08 | 5 | 137 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13 | 4.11e-08 | 6 | 137 | 4 | IPR015902 | |
| Domain | A-amylase_C | 3.86e-07 | 3 | 137 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 3.55e-06 | 15 | 137 | 4 | IPR013780 | |
| Domain | Glyco_hydro_catalytic_dom | 8.15e-06 | 38 | 137 | 5 | IPR013781 | |
| Domain | EGF-like_CS | 2.31e-05 | 261 | 137 | 10 | IPR013032 | |
| Domain | EGF_2 | 2.63e-05 | 265 | 137 | 10 | PS01186 | |
| Domain | EGF | 4.00e-05 | 126 | 137 | 7 | PF00008 | |
| Domain | Glycoside_hydrolase_SF | 4.27e-05 | 53 | 137 | 5 | IPR017853 | |
| Domain | EGF_3 | 6.02e-05 | 235 | 137 | 9 | PS50026 | |
| Domain | C8 | 8.09e-05 | 12 | 137 | 3 | PF08742 | |
| Domain | TIL | 8.09e-05 | 12 | 137 | 3 | PF01826 | |
| Domain | EGF-like_dom | 9.37e-05 | 249 | 137 | 9 | IPR000742 | |
| Domain | Unchr_dom_Cys-rich | 1.05e-04 | 13 | 137 | 3 | IPR014853 | |
| Domain | C8 | 1.05e-04 | 13 | 137 | 3 | SM00832 | |
| Domain | EGF_1 | 1.12e-04 | 255 | 137 | 9 | PS00022 | |
| Domain | - | 1.22e-04 | 35 | 137 | 4 | 3.20.20.80 | |
| Domain | TIL_dom | 1.32e-04 | 14 | 137 | 3 | IPR002919 | |
| Domain | - | 1.32e-04 | 14 | 137 | 3 | 2.60.40.1180 | |
| Domain | VWF_type-D | 2.02e-04 | 16 | 137 | 3 | IPR001846 | |
| Domain | VWFD | 2.02e-04 | 16 | 137 | 3 | PS51233 | |
| Domain | VWD | 2.02e-04 | 16 | 137 | 3 | SM00216 | |
| Domain | VWD | 2.02e-04 | 16 | 137 | 3 | PF00094 | |
| Domain | VWF_dom | 2.50e-04 | 42 | 137 | 4 | IPR001007 | |
| Domain | EGF_CA | 2.81e-04 | 122 | 137 | 6 | SM00179 | |
| Domain | KU | 2.91e-04 | 18 | 137 | 3 | SM00131 | |
| Domain | - | 2.91e-04 | 18 | 137 | 3 | 4.10.410.10 | |
| Domain | Prtase_inh_Kunz-CS | 2.91e-04 | 18 | 137 | 3 | IPR020901 | |
| Domain | EGF-like_Ca-bd_dom | 3.07e-04 | 124 | 137 | 6 | IPR001881 | |
| Domain | Pecanex_C | 3.17e-04 | 4 | 137 | 2 | PF05041 | |
| Domain | Pecanex | 3.17e-04 | 4 | 137 | 2 | IPR007735 | |
| Domain | BPTI_KUNITZ_1 | 3.43e-04 | 19 | 137 | 3 | PS00280 | |
| Domain | VWC_out | 3.43e-04 | 19 | 137 | 3 | SM00215 | |
| Domain | BPTI_KUNITZ_2 | 3.43e-04 | 19 | 137 | 3 | PS50279 | |
| Domain | Kunitz_BPTI | 3.43e-04 | 19 | 137 | 3 | PF00014 | |
| Domain | EGF | 3.46e-04 | 235 | 137 | 8 | SM00181 | |
| Domain | DCN-prot | 5.26e-04 | 5 | 137 | 2 | IPR014764 | |
| Domain | PONY_dom | 5.26e-04 | 5 | 137 | 2 | IPR005176 | |
| Domain | DCUN1 | 5.26e-04 | 5 | 137 | 2 | PS51229 | |
| Domain | Cullin_binding | 5.26e-04 | 5 | 137 | 2 | PF03556 | |
| Domain | Kunitz_BPTI | 6.14e-04 | 23 | 137 | 3 | IPR002223 | |
| Domain | EGF_Ca-bd_CS | 7.41e-04 | 97 | 137 | 5 | IPR018097 | |
| Domain | Hexokinase | 7.86e-04 | 6 | 137 | 2 | IPR001312 | |
| Domain | EGF_CA | 8.13e-04 | 99 | 137 | 5 | PS01187 | |
| Domain | Growth_fac_rcpt_ | 1.03e-03 | 156 | 137 | 6 | IPR009030 | |
| Domain | VWFC_2 | 2.70e-03 | 38 | 137 | 3 | PS50184 | |
| Domain | VWC | 2.70e-03 | 38 | 137 | 3 | SM00214 | |
| Domain | EGF_CA | 3.70e-03 | 86 | 137 | 4 | PF07645 | |
| Domain | ASX_HYDROXYL | 6.31e-03 | 100 | 137 | 4 | PS00010 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 2.00e-09 | 9 | 100 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 7.25e-09 | 11 | 100 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 4.94e-07 | 23 | 100 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.40e-06 | 28 | 100 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.71e-06 | 52 | 100 | 6 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.89e-05 | 8 | 100 | 3 | MM14717 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.22e-05 | 90 | 100 | 6 | M631 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 6.07e-05 | 96 | 100 | 6 | M39581 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.27e-04 | 69 | 100 | 5 | M16894 | |
| Pathway | BIOCARTA_AMI_PATHWAY | 3.62e-04 | 20 | 100 | 3 | M15394 | |
| Pathway | REACTOME_DIGESTION | 4.20e-04 | 21 | 100 | 3 | MM15526 | |
| Pubmed | 6.10e-12 | 6 | 141 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 6.10e-12 | 6 | 141 | 5 | 2788608 | |
| Pubmed | 6.10e-12 | 6 | 141 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 6.10e-12 | 6 | 141 | 5 | 6608795 | |
| Pubmed | 6.10e-12 | 6 | 141 | 5 | 2081604 | ||
| Pubmed | 5.66e-11 | 8 | 141 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 2.59e-10 | 4 | 141 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 2.59e-10 | 4 | 141 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 2.59e-10 | 4 | 141 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 2.59e-10 | 4 | 141 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 2.59e-10 | 4 | 141 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 2.59e-10 | 4 | 141 | 4 | 94264 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 3872721 | ||
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 2.59e-10 | 4 | 141 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 2.59e-10 | 4 | 141 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 2.59e-10 | 4 | 141 | 4 | 2987507 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 6091898 | ||
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 2.59e-10 | 4 | 141 | 4 | 6162108 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 16152770 | ||
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 2423416 | ||
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 2.59e-10 | 4 | 141 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 2.59e-10 | 4 | 141 | 4 | 2989529 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 2.59e-10 | 4 | 141 | 4 | 1141004 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 2.59e-10 | 4 | 141 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 2.59e-10 | 4 | 141 | 4 | 6207174 | |
| Pubmed | 2.59e-10 | 4 | 141 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 2.59e-10 | 4 | 141 | 4 | 2332419 | |
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 6529441 | ||
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.29e-09 | 5 | 141 | 4 | 34276419 | |
| Pubmed | 1.29e-09 | 5 | 141 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.29e-09 | 5 | 141 | 4 | 8661735 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 2002257 | ||
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 3.86e-09 | 6 | 141 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 3.86e-09 | 6 | 141 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 3.86e-09 | 6 | 141 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 3.86e-09 | 6 | 141 | 4 | 7859283 | |
| Pubmed | 3.86e-09 | 6 | 141 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 3.86e-09 | 6 | 141 | 4 | 1021597 | |
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 8.97e-09 | 7 | 141 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 8.97e-09 | 7 | 141 | 4 | 2451911 | |
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 7949740 | ||
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 6160178 | ||
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 8604219 | ||
| Pubmed | 8.97e-09 | 7 | 141 | 4 | 8666240 | ||
| Pubmed | 1.79e-08 | 8 | 141 | 4 | 2040456 | ||
| Pubmed | 1.79e-08 | 8 | 141 | 4 | 3038891 | ||
| Pubmed | 1.79e-08 | 8 | 141 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 1.79e-08 | 8 | 141 | 4 | 7523515 | |
| Pubmed | 1.79e-08 | 8 | 141 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 1.79e-08 | 8 | 141 | 4 | 6200103 | |
| Pubmed | 3.21e-08 | 9 | 141 | 4 | 93520 | ||
| Pubmed | Genetic mapping of the murine gene and 14 related sequences encoding chromosomal protein HMG-14. | 4.07e-08 | 24 | 141 | 5 | 1360278 | |
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 9121556 | ||
| Pubmed | 5.33e-08 | 10 | 141 | 4 | 2897103 | ||
| Pubmed | 6.26e-08 | 26 | 141 | 5 | 7905852 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 6.52e-08 | 3 | 141 | 3 | 2413838 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 6.52e-08 | 3 | 141 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 6.52e-08 | 3 | 141 | 3 | 6360562 | |
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 6.52e-08 | 3 | 141 | 3 | 2436036 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 6.52e-08 | 3 | 141 | 3 | 6180955 | |
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 6.52e-08 | 3 | 141 | 3 | 17223109 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 15299664 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 8413315 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 22063648 | ||
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 6.52e-08 | 3 | 141 | 3 | 7678001 | |
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 6098446 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 30982860 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 1699843 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 12527308 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 2414282 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 28659346 | ||
| Pubmed | 6.52e-08 | 3 | 141 | 3 | 25588701 | ||
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 23449223 | ||
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 7608209 | ||
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 1617215 | ||
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 2903254 | ||
| Pubmed | 8.36e-08 | 11 | 141 | 4 | 2565740 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 8.36e-08 | 11 | 141 | 4 | 7493641 | |
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 8.36e-08 | 11 | 141 | 4 | 8589528 | |
| Pubmed | 1.25e-07 | 12 | 141 | 4 | 8144363 | ||
| Pubmed | 1.80e-07 | 13 | 141 | 4 | 489953 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 1.80e-07 | 13 | 141 | 4 | 7829080 | |
| Pubmed | 2.51e-07 | 14 | 141 | 4 | 2902233 | ||
| Pubmed | 2.51e-07 | 14 | 141 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 2.51e-07 | 14 | 141 | 4 | 8001974 | |
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 2458567 | ||
| Pubmed | 2.60e-07 | 4 | 141 | 3 | 20939500 | ||
| Pubmed | Expression of sulfated gp300 and changes in glycosylation during pancreatic development. | 2.60e-07 | 4 | 141 | 3 | 8543783 | |
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 2.60e-07 | 4 | 141 | 3 | 16786601 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | AMBP AMY1A AMY1B AMY1C AMY2A AMY2B GPX3 GPD1L THBS4 IGF2R PXDN TSPAN8 CD59 PRKAR2A C3 C8A PROS1 LILRB4 | 3.67e-07 | 1070 | 141 | 18 | 23533145 |
| Pubmed | 4.54e-07 | 16 | 141 | 4 | 2571572 | ||
| Cytoband | 1p21 | 1.03e-08 | 24 | 141 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 2.10e-05 | 107 | 141 | 5 | chr1p21 | |
| Cytoband | 7q22 | 2.21e-04 | 38 | 141 | 3 | 7q22 | |
| GeneFamily | Protein phosphatase 6 regulatory subunits | 2.52e-06 | 6 | 92 | 3 | 699 | |
| GeneFamily | CD molecules|Mucins | 1.59e-04 | 21 | 92 | 3 | 648 | |
| GeneFamily | Complement system|Sushi domain containing | 8.06e-04 | 36 | 92 | 3 | 492 | |
| GeneFamily | Collagens | 1.65e-03 | 46 | 92 | 3 | 490 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.32e-03 | 181 | 92 | 5 | 694 | |
| GeneFamily | Ubiquitin specific peptidases | 2.91e-03 | 56 | 92 | 3 | 366 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 3.96e-03 | 394 | 92 | 7 | 471 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.63e-03 | 66 | 92 | 3 | 722 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | WASHC4 ATRX GNE ITGA6 SIK3 TFPI CEP170 USP6 SETD2 RAB3GAP1 ZZZ3 IGF2R DST ATAD2B ANKRD28 KLHDC10 ZMYM4 GOLGA4 | 7.58e-07 | 856 | 140 | 18 | M4500 |
| Coexpression | LEE_AGING_MUSCLE_UP | 2.60e-06 | 41 | 140 | 5 | MM698 | |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 4.53e-06 | 80 | 140 | 6 | MM646 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | SELP PPP1R9A ZNF521 TENM2 THBS4 DCUN1D1 IGF2R DST PXDN CD59 DNAI4 PRKCE LTBP1 ZMYM4 SEMA3E | 7.68e-06 | 721 | 140 | 15 | M1999 |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.22e-05 | 143 | 140 | 7 | MM1056 | |
| Coexpression | ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR | 1.47e-05 | 98 | 140 | 6 | M39210 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 1.75e-05 | 60 | 140 | 5 | MM654 | |
| Coexpression | BERGER_MBD2_TARGETS | 2.38e-05 | 11 | 140 | 3 | MM905 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A6 KALRN CCDC28A DNER SMG5 SLC45A4 CDCA2 ANKRD44 DST PXDN PRKAR2A PLEKHA1 ANKRD28 PCNX1 ARHGAP28 LTBP1 GOLGA4 PROS1 | 2.46e-05 | 1102 | 140 | 18 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | COL4A6 KALRN CCDC28A DNER SMG5 SLC45A4 CDCA2 ANKRD44 DST PXDN PRKAR2A PLEKHA1 ANKRD28 PCNX1 ARHGAP28 LTBP1 GOLGA4 PROS1 | 3.18e-05 | 1124 | 140 | 18 | MM1070 |
| Coexpression | LEE_AGING_NEOCORTEX_DN | 3.22e-05 | 68 | 140 | 5 | M1497 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | WASHC4 ATRX CEP170 USP6 SETD2 RAB3GAP1 ZZZ3 DST ATAD2B ZMYM4 GOLGA4 | 4.32e-05 | 466 | 140 | 11 | M13522 |
| Coexpression | JAATINEN_HEMATOPOIETIC_STEM_CELL_UP | 6.25e-05 | 323 | 140 | 9 | M15107 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | AMY1B AMY1C AMY2A AMY2B TENM2 PREX2 MICU1 DST GIMAP8 TSPAN8 CD59 ARHGAP28 NOCT PROS1 SEMA3E | 8.43e-05 | 888 | 140 | 15 | MM1018 |
| Coexpression | GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP | 8.83e-05 | 195 | 140 | 7 | M6899 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_UP | 1.00e-04 | 199 | 140 | 7 | M5508 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 1.15e-04 | 18 | 140 | 3 | M47984 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | SELP PPP1R9A ZNF521 ITGA6 SLC43A3 TFPI CDCA2 CD93 DCUN1D1 ARHGEF40 DST ANKRD28 PRKCE C3 PRDM16 | 1.09e-07 | 422 | 138 | 15 | GSM399442_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_500 | 4.46e-06 | 66 | 138 | 6 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_k3_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | SELP PPP1R9A ZNF521 ITGA6 TFPI CD93 DCUN1D1 DST ANKRD28 PRKCE C3 PRDM16 | 1.52e-05 | 409 | 138 | 12 | GSM476663_500 |
| CoexpressionAtlas | Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3 | HK3 PPP1R9A ZNF521 ITGA6 TFPI CD93 DCUN1D1 ARHGEF40 DST ANKRD28 PRKCE C3 | 2.12e-05 | 423 | 138 | 12 | GSM399454_500 |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-08 | 198 | 141 | 9 | 9e103228ac2cc86eec58bc6b8e142965228e8853 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-08 | 198 | 141 | 9 | 55378e15360f867c9500b03293814965562ae55d | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.46e-08 | 198 | 141 | 9 | 12697db1e516c2afdb5fa1ca8caa06f4abed3382 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.60e-08 | 200 | 141 | 9 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-07 | 189 | 141 | 8 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.85e-07 | 192 | 141 | 8 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.93e-07 | 193 | 141 | 8 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | background-Endothelial_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.09e-07 | 195 | 141 | 8 | c7d60dabfc7cb310e002cab10003dadfcc34fe33 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-07 | 196 | 141 | 8 | cf7f384c1771274e766bab03ecc3dfbd13f2df60 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.26e-07 | 197 | 141 | 8 | 56afed433887cb2766eb30f22aec195148db33ab | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-07 | 198 | 141 | 8 | 1b9200e30f1d9b91bb0c6411c4f95208aedbe161 | |
| ToppCell | normal_Lung-Endothelial_cells-Stalk-like_ECs|normal_Lung / Location, Cell class and cell subclass | 2.34e-07 | 198 | 141 | 8 | 2a251d13c2488d15ca9b11e643c1d17d428b6ef0 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-07 | 198 | 141 | 8 | b11d21aa96a0c91e958ae7ed8fd56546aeaebb91 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-07 | 198 | 141 | 8 | 7e2d6e21b2b3d5a4a9f786890ec6ba2688a506cc | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-07 | 198 | 141 | 8 | 605ef5b61750226b93bca48166d8a1f6450e80e0 | |
| ToppCell | (6)_Endothelial-E|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.34e-07 | 198 | 141 | 8 | a5e1b321376caf262ea48904d31afd1b8e9d3be2 | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-07 | 199 | 141 | 8 | 636ff80938907f137e955388797072ab45289062 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-07 | 199 | 141 | 8 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-07 | 200 | 141 | 8 | ecb6d3f7181a0f3c6bf197fc69bed0696d711199 | |
| ToppCell | Biopsy_Control_(H.)-Endothelial-Endothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.53e-07 | 200 | 141 | 8 | 0242d465da2dfba0da629a43e152949c5192465b | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.57e-07 | 142 | 141 | 7 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.74e-07 | 143 | 141 | 7 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.15e-06 | 169 | 141 | 7 | f086b50791e1c93e253eb5e8d6c4bf617b1416c3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.30e-06 | 172 | 141 | 7 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 1.51e-06 | 176 | 141 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-MK-early_MK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-06 | 179 | 141 | 7 | d5b9c610c1519804b1753fed1b505293ea590867 | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-06 | 185 | 141 | 7 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.18e-06 | 186 | 141 | 7 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-06 | 186 | 141 | 7 | a844d4f79e0ad5d6c60a4488ffd8f4f21b7eed04 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-06 | 187 | 141 | 7 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-06 | 187 | 141 | 7 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 2.26e-06 | 187 | 141 | 7 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.34e-06 | 188 | 141 | 7 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.34e-06 | 188 | 141 | 7 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 190 | 141 | 7 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.51e-06 | 190 | 141 | 7 | b4088128f5acf53f43244c9af9fe44e033f1a57a | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.60e-06 | 191 | 141 | 7 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 192 | 141 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Vein|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 192 | 141 | 7 | 717f3d3bbee4d0f64ba1341ee2b00a407ba1e0f3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 193 | 141 | 7 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 2.79e-06 | 193 | 141 | 7 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.79e-06 | 193 | 141 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-06 | 193 | 141 | 7 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 193 | 141 | 7 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 2.79e-06 | 193 | 141 | 7 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.79e-06 | 193 | 141 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 194 | 141 | 7 | cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-06 | 194 | 141 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | ASK440-Endothelial-Endothelium|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.99e-06 | 195 | 141 | 7 | 304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 83da75d210ae9c2a94018d70cb9e833b37004c4e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 2.99e-06 | 195 | 141 | 7 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | ASK428-Endothelial-Endothelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.09e-06 | 196 | 141 | 7 | b1a81eddb91fb462360692b7b0a3ba4a947eac40 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.09e-06 | 196 | 141 | 7 | ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42 | |
| ToppCell | distal-Endothelial-Vein-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.19e-06 | 197 | 141 | 7 | 3d71c93da4b88ebbd58e68ed3dbf610d4bcfc4f5 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.19e-06 | 197 | 141 | 7 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 3.19e-06 | 197 | 141 | 7 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-06 | 198 | 141 | 7 | 68ee0baa2f5cf239f2356cc59fee9041a7732bba | |
| ToppCell | (6)_Endothelial_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.30e-06 | 198 | 141 | 7 | f38f49d532fa6211f57e36ee494478bdd3f4f89c | |
| ToppCell | 343B-Endothelial_cells|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-06 | 198 | 141 | 7 | fab32347580c7a81ef1fe4fe7b325d9105a947d9 | |
| ToppCell | distal-Endothelial-Artery-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-06 | 198 | 141 | 7 | f284f59f4ebe55ee132eddfaa2f5d9ecb059654f | |
| ToppCell | distal-1-Endothelial-Vein|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.30e-06 | 198 | 141 | 7 | eee6cb4fe0e1caf460869d5a0a57c9d259573f10 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-06 | 198 | 141 | 7 | 71ee440b1ac566db63d0b415c50a0ad064d14f15 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-06 | 199 | 141 | 7 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | distal-3-Endothelial-Artery|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-06 | 199 | 141 | 7 | 7814804f4ecc0655610e5c85f513b3976d856192 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-06 | 199 | 141 | 7 | d66514bdffdd96468b543ec96041e42c12472e66 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-06 | 199 | 141 | 7 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-06 | 199 | 141 | 7 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|normal_Lung / Location, Cell class and cell subclass | 3.41e-06 | 199 | 141 | 7 | 1ae0b47fade7b1cd74c0faabcf4f12f56f62264e | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-06 | 199 | 141 | 7 | 6cfe5a3d0ad530411ebc11decb4ab4c529e018d5 | |
| ToppCell | distal-1-Endothelial-Artery|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.41e-06 | 199 | 141 | 7 | fd71d08f6de790a29c880d50d2ed0881952d7791 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 3.41e-06 | 199 | 141 | 7 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.41e-06 | 199 | 141 | 7 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | 5'-Parenchyma_lung-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-06 | 199 | 141 | 7 | c0a1ed48bebcd85cbbffb8ac50fb0f902b97f239 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | 29ed081bd5204a32068b420f2244f3704891547b | |
| ToppCell | 367C-Endothelial_cells-Endothelial-A_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 199 | 141 | 7 | c2d85f80037f209a4a329790f475d9f98f590262 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.41e-06 | 199 | 141 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-06 | 200 | 141 | 7 | ec9a18576a3d08ddfceb70d114c4ab861fbb0d08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-06 | 200 | 141 | 7 | 622206c33640cb2694fe158e8dc55515bb7bd4f5 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Artery|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | 34b279804475ea58fbb052b96f44128c082627a9 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Artery|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | 5b4a54cd81bc4d9f5e92798362239e1aa1b70bee | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | 8552cc7a439449b30b59760c3e8667217b9852b5 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-06 | 200 | 141 | 7 | 24e43d3d16d07571f77e0cd5b2e4758c6ff802cb | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-06 | 200 | 141 | 7 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 | |
| ToppCell | medial-Endothelial|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | e889b593c2ae53c42944213ce8672cd886917105 | |
| ToppCell | medial-2-Endothelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | 70440db2d8be1e29aeb34ea5e8ac72641b5c056f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 200 | 141 | 7 | d9dab2aed11e45c60d11ff0c5af1f2fbb9cb45d8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.53e-06 | 200 | 141 | 7 | 33b7af6c50e65dc1bdf429572574ed072f8bc29f | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Artery|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | 590d1c0f86f136c7e76ea107fbb8ac5ff1164386 | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Artery-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.53e-06 | 200 | 141 | 7 | 45c08f1befe78553bbadcc2fcffb6138306638f3 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | Control-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 5.21e-06 | 138 | 141 | 6 | b7920c9a28d28220e7e4b30cd91ba13d0548eb76 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.05e-05 | 156 | 141 | 6 | bb2876bdf2375866d7509eba3c48322326349fa8 | |
| Drug | trestatin A | 4.01e-12 | 9 | 140 | 6 | CID003054994 | |
| Drug | FG5P | 2.19e-11 | 11 | 140 | 6 | CID000127486 | |
| Drug | R 623 | 4.88e-11 | 6 | 140 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 4.88e-11 | 6 | 140 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 4.88e-11 | 6 | 140 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 4.88e-11 | 6 | 140 | 5 | CID000127364 | |
| Drug | CNP-G3 | 4.88e-11 | 6 | 140 | 5 | CID003082910 | |
| Drug | isoacarbose | 8.04e-11 | 13 | 140 | 6 | CID000449165 | |
| Drug | AC1L5BOU | 1.70e-10 | 7 | 140 | 5 | CID000174858 | |
| Drug | BG5P | 1.70e-10 | 7 | 140 | 5 | CID003082752 | |
| Drug | desethylaprophen | 4.51e-10 | 8 | 140 | 5 | CID000163919 | |
| Drug | azintamide | 4.51e-10 | 8 | 140 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 1.01e-09 | 9 | 140 | 5 | CID000194237 | |
| Drug | N-PMT | 1.37e-09 | 4 | 140 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 1.37e-09 | 4 | 140 | 4 | CID003482066 | |
| Drug | SAIB-SG | 1.37e-09 | 4 | 140 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 1.37e-09 | 4 | 140 | 4 | CID013573844 | |
| Drug | Dembrexine | 1.37e-09 | 4 | 140 | 4 | CID000072009 | |
| Drug | g lw | 1.37e-09 | 4 | 140 | 4 | CID000444139 | |
| Drug | beta-santalene | 1.37e-09 | 4 | 140 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 2.01e-09 | 10 | 140 | 5 | CID000485275 | |
| Drug | eicosa-11,14-dienoic acid | 2.01e-09 | 10 | 140 | 5 | CID000003208 | |
| Drug | Glc)4 | 2.01e-09 | 10 | 140 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 2.01e-09 | 10 | 140 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 2.01e-09 | 10 | 140 | 5 | CID000118008 | |
| Drug | maltosaccharide | 3.34e-09 | 22 | 140 | 6 | CID005461034 | |
| Drug | L-tert-leucine | 3.67e-09 | 11 | 140 | 5 | CID000164608 | |
| Drug | validamycin D | 3.67e-09 | 11 | 140 | 5 | CID000166726 | |
| Drug | CNP-G5 | 3.67e-09 | 11 | 140 | 5 | CID000127309 | |
| Drug | HgI2 | 3.67e-09 | 11 | 140 | 5 | CID000024485 | |
| Drug | 2C KM | 3.67e-09 | 11 | 140 | 5 | CID009549196 | |
| Drug | Panose B | 5.96e-09 | 24 | 140 | 6 | CID000439297 | |
| Drug | azaprophen | 6.26e-09 | 12 | 140 | 5 | CID000129486 | |
| Drug | Deposiston | 6.81e-09 | 5 | 140 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 6.81e-09 | 5 | 140 | 4 | CID010358258 | |
| Drug | lunularic acid | 6.81e-09 | 5 | 140 | 4 | CID000161413 | |
| Drug | himachalene | 6.81e-09 | 5 | 140 | 4 | CID000015095 | |
| Drug | actinidine | 6.81e-09 | 5 | 140 | 4 | CID000068231 | |
| Drug | 2TAA | 6.81e-09 | 5 | 140 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 6.81e-09 | 5 | 140 | 4 | CID006449879 | |
| Drug | silver perchlorate | 6.81e-09 | 5 | 140 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 6.81e-09 | 5 | 140 | 4 | CID000155287 | |
| Drug | methyl 1'-epiacarviosin | 1.01e-08 | 13 | 140 | 5 | CID000197426 | |
| Drug | maackiain | 1.01e-08 | 13 | 140 | 5 | CID000091510 | |
| Drug | Cyclodextrins | 1.57e-08 | 14 | 140 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 1.57e-08 | 14 | 140 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 1.57e-08 | 14 | 140 | 5 | CID000007488 | |
| Drug | 2-amino-6-picoline | 2.03e-08 | 6 | 140 | 4 | CID000015765 | |
| Drug | phenol blue | 2.03e-08 | 6 | 140 | 4 | CID000075078 | |
| Drug | Gu-4 | 2.03e-08 | 6 | 140 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 2.03e-08 | 6 | 140 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 2.03e-08 | 6 | 140 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 2.03e-08 | 6 | 140 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 2.03e-08 | 6 | 140 | 4 | CID006857368 | |
| Drug | vermella | 2.03e-08 | 6 | 140 | 4 | CID000203726 | |
| Drug | hymenin | 2.03e-08 | 6 | 140 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 2.03e-08 | 6 | 140 | 4 | CID000011615 | |
| Drug | 4-nitrophenylmaltoheptaoside | 2.34e-08 | 15 | 140 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 3.38e-08 | 16 | 140 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 3.38e-08 | 16 | 140 | 5 | CID003085308 | |
| Drug | R625 | 4.69e-08 | 33 | 140 | 6 | CID000072375 | |
| Drug | methyl blue | 4.72e-08 | 7 | 140 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 4.72e-08 | 7 | 140 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 4.72e-08 | 7 | 140 | 4 | CID000071762 | |
| Drug | Paramax | 4.72e-08 | 7 | 140 | 4 | CID000156411 | |
| Drug | amino-methyl | 4.72e-08 | 7 | 140 | 4 | CID000142005 | |
| Drug | trimitan | 6.57e-08 | 18 | 140 | 5 | CID000005561 | |
| Drug | sucrose-6-phosphate | 6.57e-08 | 18 | 140 | 5 | CID000644101 | |
| Drug | aprophen | 6.57e-08 | 18 | 140 | 5 | CID000071128 | |
| Drug | AC1LA2MZ | 6.62e-08 | 58 | 140 | 7 | CID000460551 | |
| Drug | boric acid gel | 9.40e-08 | 8 | 140 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 9.40e-08 | 8 | 140 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 9.40e-08 | 8 | 140 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 9.40e-08 | 8 | 140 | 4 | CID000146692 | |
| Drug | acrinor | 9.40e-08 | 8 | 140 | 4 | CID005489637 | |
| Drug | NSC300622 | 9.40e-08 | 8 | 140 | 4 | CID000028426 | |
| Drug | theodrenaline | 9.40e-08 | 8 | 140 | 4 | CID000071857 | |
| Drug | rhodanile blue | 9.40e-08 | 8 | 140 | 4 | CID000073372 | |
| Drug | AC1L3XPY | 1.54e-07 | 21 | 140 | 5 | CID000124005 | |
| Drug | digoxigenine | 1.57e-07 | 40 | 140 | 6 | CID000015478 | |
| Drug | maltoheptose | 1.57e-07 | 40 | 140 | 6 | CID003037125 | |
| Drug | GSAD | 1.68e-07 | 9 | 140 | 4 | CID009909127 | |
| Drug | GU-3 | 1.68e-07 | 9 | 140 | 4 | CID000448687 | |
| Drug | zingiberene | 1.68e-07 | 9 | 140 | 4 | CID000092776 | |
| Drug | Atonik | 1.68e-07 | 9 | 140 | 4 | CID000069471 | |
| Drug | H 187 | 1.68e-07 | 9 | 140 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 1.68e-07 | 9 | 140 | 4 | CID000024864 | |
| Drug | Bz-C | 1.98e-07 | 22 | 140 | 5 | CID000001511 | |
| Drug | AC1N3UXZ | 2.28e-07 | 3 | 140 | 3 | CID004118625 | |
| Drug | I ZE | 2.79e-07 | 10 | 140 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 2.79e-07 | 10 | 140 | 4 | CID000012135 | |
| Drug | CG-120 | 2.79e-07 | 10 | 140 | 4 | CID000171403 | |
| Drug | UDP-pyridoxal | 2.79e-07 | 10 | 140 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 2.79e-07 | 10 | 140 | 4 | CID000440202 | |
| Drug | CID439354 | 3.94e-07 | 25 | 140 | 5 | CID000439354 | |
| Drug | Tempamine | 4.37e-07 | 11 | 140 | 4 | CID000550942 | |
| Drug | AMO-1618 | 4.37e-07 | 11 | 140 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 4.37e-07 | 11 | 140 | 4 | CID000430710 | |
| Drug | chloroisocyanuric acid | 6.52e-07 | 12 | 140 | 4 | CID000017921 | |
| Drug | glyciphosphoramide | 6.52e-07 | 12 | 140 | 4 | CID000197092 | |
| Disease | alpha-amylase 1 measurement | 5.19e-08 | 9 | 135 | 4 | EFO_0801371 | |
| Disease | protein S deficiency (is_implicated_in) | 2.08e-05 | 2 | 135 | 2 | DOID:2451 (is_implicated_in) | |
| Disease | Activated Protein C Resistance | 2.08e-05 | 2 | 135 | 2 | C0600433 | |
| Disease | Colorectal Carcinoma | COL4A6 FLNC HK3 KALRN PREX2 CD93 MLH3 ZZZ3 PRKCE ZMYM4 PROS1 | 3.97e-04 | 702 | 135 | 11 | C0009402 |
| Disease | Complement deficiency disease | 4.62e-04 | 33 | 135 | 3 | C0272242 | |
| Disease | sulfatase-modifying factor 1 measurement | 5.71e-04 | 8 | 135 | 2 | EFO_0802098 | |
| Disease | retinal vasculature measurement | 6.46e-04 | 517 | 135 | 9 | EFO_0010554 | |
| Disease | lifestyle measurement, systolic blood pressure | 7.32e-04 | 9 | 135 | 2 | EFO_0006335, EFO_0010724 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 8.66e-04 | 160 | 135 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | acute necrotizing pancreatitis (implicated_via_orthology) | 9.13e-04 | 10 | 135 | 2 | DOID:0080998 (implicated_via_orthology) | |
| Disease | reaction time measurement | PPP1R9A MUC19 ZNF521 TENM2 ANKRD44 SETD2 ATAD2B CCDC68 DNAI4 PRKCE | 9.23e-04 | 658 | 135 | 10 | EFO_0008393 |
| Disease | unipolar depression | EMILIN3 CHST9 TENM2 LIN28A CDCA2 ANKRD44 SC5D TMEM132D CCDC68 APPL1 NOCT NOS1 ZMYM4 SEMA3E | 1.29e-03 | 1206 | 135 | 14 | EFO_0003761 |
| Disease | hemolysis | 1.31e-03 | 47 | 135 | 3 | EFO_0009473 | |
| Disease | Neurobehavioral Manifestations | 1.33e-03 | 12 | 135 | 2 | C0525041 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Heschl's gyrus morphology measurement | 1.86e-03 | 53 | 135 | 3 | EFO_0005852 | |
| Disease | 3-hydroxyanthranilic acid measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0010447 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 2.43e-03 | 122 | 135 | 4 | EFO_0009264, EFO_0010724 | |
| Disease | intraocular pressure measurement | 2.44e-03 | 509 | 135 | 8 | EFO_0004695 | |
| Disease | mean platelet volume | ZAN PCDHGB5 KALRN ITGA6 SIK3 SLC45A4 SETD2 ATAD2B CCDC68 ANKRD28 LTBP1 PRDM16 | 2.58e-03 | 1020 | 135 | 12 | EFO_0004584 |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 2.63e-03 | 206 | 135 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | triglycerides to total lipids in large HDL percentage | 2.65e-03 | 60 | 135 | 3 | EFO_0022330 | |
| Disease | Antibody Deficiency Syndrome | 2.70e-03 | 17 | 135 | 2 | C0003257 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.70e-03 | 17 | 135 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | glomerulonephritis (implicated_via_orthology) | 2.70e-03 | 17 | 135 | 2 | DOID:2921 (implicated_via_orthology) | |
| Disease | nephrotic syndrome (is_marker_for) | 3.03e-03 | 18 | 135 | 2 | DOID:1184 (is_marker_for) | |
| Disease | neck circumference | 3.38e-03 | 19 | 135 | 2 | EFO_0011043 | |
| Disease | corneal hysteresis | 3.74e-03 | 20 | 135 | 2 | EFO_0010066 | |
| Disease | myeloid white cell count | SELP SIK3 ZKSCAN5 PREX2 SLC45A4 SETD2 SLC18A1 ATAD2B NLRC5 PRKCE C3 | 3.93e-03 | 937 | 135 | 11 | EFO_0007988 |
| Disease | triglycerides to total lipids in small HDL percentage | 4.44e-03 | 72 | 135 | 3 | EFO_0022336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AQGEACVQFQALKGQ | 61 | O95150 | |
| GNGNNFVTEKECLQT | 266 | P02760 | |
| GCGIDAKQVEEQSAA | 211 | Q5SW79 | |
| EETQQCKFDGQETKG | 36 | Q8IV48 | |
| GIKSCDFQAARNNEE | 6 | P16452 | |
| QEKAHNQDLGFAGSC | 1501 | Q14031 | |
| CGFQGAEVLSENDLK | 636 | Q8TER5 | |
| AACEQTQTEGAKADG | 526 | P07357 | |
| QCNDIVFGFGSKDDE | 256 | Q5T601 | |
| CNQFGKQEPGENSEI | 101 | P22352 | |
| VSKNEGCQAGAELEE | 276 | Q9H116 | |
| ANVACGEGDKDETQS | 221 | Q9NPY3 | |
| FNDGKCKTGSGDIEN | 151 | P0DTE7 | |
| FNDGKCKTGSGDIEN | 151 | P0DTE8 | |
| IQSGAVIDCEDKNGN | 326 | O15084 | |
| ENQKQCQDLGAFTES | 1641 | P01024 | |
| FNDGKCKTGSGDIEN | 151 | P0DUB6 | |
| FNDGKCKTGSGDIEN | 151 | P19961 | |
| IQNGSEIDCADKFGN | 326 | Q8NB46 | |
| DAKHCGNLQQGSDSE | 66 | Q9H2F9 | |
| KDLCNFNEQLENGGT | 91 | P13987 | |
| GNCQTEFEGVHSQKQ | 211 | Q9BXU9 | |
| QNQGDIKLCEGFNEV | 126 | Q9Y6H1 | |
| QDENKIGIDGIQQFC | 76 | Q96GG9 | |
| NGICKNVGCDFEIDS | 666 | Q9UKP4 | |
| FECLSDTEELKGNGQ | 586 | Q15042 | |
| FNDGKCKTGSGDIEN | 151 | P04746 | |
| CGNFDGKVTNEFVSE | 176 | Q6W4X9 | |
| KSKAECDNVGSVENG | 251 | Q9P2G4 | |
| EGAKCQGEENASFSQ | 81 | P43366 | |
| EDQCLGGAQATAAEK | 21 | A8MXT2 | |
| NETAFCLGKESENGL | 516 | Q8IWI9 | |
| FCGDVGQNKFEEVDV | 416 | Q96JK4 | |
| FGNFLGNCQKDREDL | 436 | Q96EF0 | |
| AADVQGENFCAAVKN | 321 | Q8NHJ6 | |
| GENFCAAVKNTQPED | 326 | Q8NHJ6 | |
| GANIANEVAAEKFCE | 151 | Q8N335 | |
| EGGNQQQAASEKESC | 1326 | Q13439 | |
| DVGKNDFLQSERCAN | 3071 | Q03001 | |
| DFLQSERCANGLGND | 3076 | Q03001 | |
| GCVASQNGEDAIKQH | 651 | Q02156 | |
| QNGKLEVVSFCDSGD | 1286 | Q9ULI0 | |
| FESNNEGEKICDSVG | 606 | Q9UKG1 | |
| SGKLQAFGNECSIEQ | 191 | Q8IWP9 | |
| QDENKIGVDGIQQFC | 76 | Q6PH85 | |
| DCDGNGELSNKEFVS | 421 | Q9BPX6 | |
| NEFTDQRTKAEQGNC | 96 | Q96RV3 | |
| KDCNARQHSGGNIED | 1871 | A6NKB5 | |
| FGESNGNDVHVCNVK | 176 | Q6PID8 | |
| GQGYQLSAAKDQCED | 1106 | Q14766 | |
| GFQLDDNKTCQDINE | 1191 | Q14766 | |
| DATGDQNGICFQSEE | 1011 | Q9UHC1 | |
| SPNVFNGCEEGKSQE | 311 | A8MYZ0 | |
| CGNNNGDLKDDFTTR | 1411 | Q7Z5P9 | |
| KIECQDNGDGSCAVS | 1106 | Q14315 | |
| GDKFEASKQNDLGGC | 2306 | O60229 | |
| NKATCGTVGDDNEEA | 166 | P38432 | |
| EAEQQGEAALNDAKC | 366 | Q9NSB4 | |
| IQNGGEIDCVDKDGN | 326 | Q8N8A2 | |
| LKEGCGDDNVCNSNL | 661 | P23229 | |
| KIHDQDSGENGEVNC | 366 | Q9Y5G0 | |
| VEFCQKESIGSLQNG | 116 | Q9NVV4 | |
| DCIVDFQQKQGLSGQ | 586 | P52790 | |
| CLANVDNSGNGQDKI | 26 | Q3SYG4 | |
| AQGNEDCVGAKQAAV | 581 | Q86WI3 | |
| TADGNLKVCLFGNSE | 321 | Q9NZB8 | |
| VFCVGDDVNIEKANN | 946 | P29475 | |
| KCGLGQENSDNEHLV | 626 | P46100 | |
| NGSGNRFNSEKECQE | 1106 | Q2UY09 | |
| NDGNCAALAERKFGQ | 516 | Q9Y223 | |
| SDTKCPEQDGFGNIA | 246 | Q14993 | |
| FQDCVNEAASQEGDK | 211 | Q8ND71 | |
| GGDSEIVDGFNVCQK | 226 | O75936 | |
| QFQTDSLGYCGENKE | 596 | Q5TB80 | |
| DSELVEAFGGNQNCL | 256 | Q9P203 | |
| EAFGGNQNCLDEELK | 261 | Q9P203 | |
| FEGDNVILRCQGKDN | 111 | Q96P31 | |
| SCDNGFKLEGPNNVE | 601 | P16109 | |
| AGGQNAENLCQFFKI | 741 | Q69YH5 | |
| AKQTDCLLVGDSDGQ | 801 | Q5VTH9 | |
| SNKDGGNQEVEIARC | 316 | P13861 | |
| LDGFEQKLQGVQSEC | 316 | Q9NT22 | |
| NSSCGDGIQQTQDKE | 81 | Q6PJP8 | |
| QGGSVEAAQAFLCKN | 406 | Q7Z3D6 | |
| NASCIDANEKQDGSN | 361 | Q8NFT8 | |
| LAQALGEGKDNFVQC | 151 | Q9UK39 | |
| FCQQDFAGGDIADLK | 261 | O14772 | |
| NSGCSGENKEENIKD | 106 | Q8N108 | |
| NFECNKTAGNDGKGT | 431 | P11717 | |
| KTEGENCTVFDSQAG | 621 | P11717 | |
| CGLHDGLQDTSQDKQ | 1246 | A6NKG5 | |
| AKQENFILGSCGTDQ | 56 | Q9GZN7 | |
| RGNGKFDKTGNNDCD | 1001 | Q8IWB6 | |
| FDKTGNNDCDSDQHG | 1006 | Q8IWB6 | |
| SCKQLTLAQGAGEED | 951 | Q9UPR3 | |
| VCQKKAAGSENSADG | 361 | Q14C87 | |
| LGSEKFCVDANQAGA | 151 | Q9HAZ2 | |
| LLGKQAIDDDCNQTG | 121 | P38117 | |
| AGNLLNESEKDCGQD | 51 | Q9Y448 | |
| SECSLTKGQDGLQND | 36 | Q96PZ0 | |
| QQFQDGENEECGASL | 1261 | Q9Y2K2 | |
| KGCQTNNGFVHNEDI | 16 | Q07837 | |
| NATGQADCKAQDERF | 56 | Q8NBI5 | |
| TSCADNKDNEGDGLV | 846 | Q9NT68 | |
| FDINECKDPSNINGG | 156 | P07225 | |
| GDQFNGELEASAKNV | 61 | Q5TBC7 | |
| NACEEALINGSGVKF | 316 | Q7L1S5 | |
| ISEIPFKCNGNGNEF | 236 | Q8IXR9 | |
| QKAGGAEAENCETIS | 26 | Q5BKX6 | |
| QRNSDKDIFGDACDN | 531 | P35443 | |
| DGNSGDADCFQPAVK | 336 | P32780 | |
| LFEGDSKADCAQGLQ | 471 | Q4G0A6 | |
| CGNHTNQLDGTKEER | 186 | Q9P2N2 | |
| GIQEFQATAKEACAD | 886 | Q9BX26 | |
| NCGTNGASEQVQKEE | 841 | Q96K83 | |
| EGQTVDFQCEAKGNP | 446 | Q92626 | |
| LNATLNTGKECGDEN | 391 | Q9HBJ7 | |
| AEAADSSQKNGCQLG | 106 | Q9UJ04 | |
| NSKRVCFNVAGDEQE | 1081 | Q70Z35 | |
| GGNENNFTSKQECLR | 251 | P10646 | |
| NNGLSGKCLQEAQEE | 951 | Q9BYW2 | |
| KQAGAEAQGAAEAFQ | 66 | O15195 | |
| TDQEALCAGETGAQK | 2681 | Q96JG9 | |
| DIACAVADGENAFQG | 686 | Q9H869 | |
| FQACIEQQFDSLNGG | 261 | Q2M389 | |
| DGCSGHKNQNEIDTL | 76 | A6NK53 | |
| CQEAALNKDEGNESG | 421 | Q8TF39 | |
| QCFGQQFVGDALDKT | 571 | O15041 | |
| QKQHNGENCFRGDDG | 136 | Q9HCX3 | |
| CGFLDIEENENSGKF | 11 | Q9HB21 | |
| SGNGCKNEKLFNGEF | 281 | O75845 | |
| NGLKVTDTQEAECAG | 16 | Q99614 | |
| NEKGICCDSQNNGSE | 436 | Q8IYH5 | |
| ECKGNLEGQEASQEG | 91 | Q7Z3V5 | |
| LIQNECGQGEQASEK | 331 | Q96RL1 | |
| DASKENGAGQICELA | 1226 | P35125 | |
| NLDASKENGAGQICE | 1426 | Q8NFA0 | |
| QKSGAVFDEIVENCG | 16 | Q5VZL5 | |
| VQNNLGGKVEEFCCE | 786 | Q5VZL5 | |
| QEEFKCCGLVNGAAD | 146 | P19075 | |
| QVQDFGEGCEFQGKL | 496 | Q9Y2L8 | |
| HKNNCLQGTGFLEEE | 121 | P54219 | |
| VTAKNEEQGQEGVSC | 1196 | Q9Y493 | |
| GKGDDSETDKNNCSN | 631 | P22459 | |
| DGRCNIEFGNVEAQS | 46 | P48048 | |
| PGFDFQEQCTQKAAE | 5296 | Q9UKN1 | |
| NQQFAGGCAKAAEEA | 6 | Q9H9Z2 | |
| ENLDGKQTSCQDGLS | 851 | Q9ULJ8 |